Ruan; Zheming

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ruan; Zheming.The latest application filed is for "agonists of ror gammat".

Company Profile

10.9.15

Ruan; Zheming - Dayton NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
AGONISTS OF ROR GAMMAt App 20220306630 - Harikrishnan; Lalgudi S. ; et al.	2022-09-29
Cyclic dinucleotides as anticancer agents Grant 11,339,185 - Fink , et al. May 24, 2	2022-05-24
Cyclic Dinucleotides As Anticancer Agents App 20220117995 - FINK; Brian E. ; et al.	2022-04-21
Cyclic dinucleotides as anticancer agents Grant 10,947,263 - Qin , et al. March 16, 2	2021-03-16
Cyclic Dinucleotides As Anticancer Agents App 20210002323 - FINK; Brian E. ; et al.	2021-01-07
Cyclic dinucleotides as anticancer agents Grant 10,744,150 - Fink , et al. A	2020-08-18
Cyclic Dinucleotides As Anticancer Agents App 20200223883 - Qin; Lan-Ying ; et al.	2020-07-16
Cyclic Dinucleotides As Anticancer Agents App 20200079815 - FINK; Brian E. ; et al.	2020-03-12
Cyclic dinucleotides as anticancer agents Grant 10,519,187 - Fink , et al. Dec	2019-12-31
Cyclic Dinucleotides As Anticancer Agents App 20190248828 - Fink; Brian E. ; et al.	2019-08-15
Bicyclic heteroaryl amine compounds Grant 10,214,537 - Bhide , et al. Feb	2019-02-26
Cyclic Dinucleotides As Anticancer Agents App 20190030057 - FINK; Brian E. ; et al.	2019-01-31
Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitors Grant 10,023,576 - Bhide , et al. July 17, 2	2018-07-17
Bicyclic Heteroaryl Amine Compounds App 20170355707 - Bhide; Rajeev S. ; et al.	2017-12-14
Heteroaryl Substituted Pyrrolotriazine Amine Compounds As Pi3k Inhibitors App 20170355698 - Bhide; Rajeev S. ; et al.	2017-12-14
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors Grant 8,148,396 - Li , et al. April 3, 2	2012-04-03
Inhibitors Of 11-beta Hydroxysteroid Dehydrogenase Type I App 20110077395 - Li; James J. ; et al.	2011-03-31
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors Grant 7,579,360 - Li , et al. August 25, 2	2009-08-25
Triazolopyridine 11-beta Hydroxysteroid Dehydrogenase Type I Inhibitors App 20090203668 - Li; James J. ; et al.	2009-08-13
Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators Grant 7,459,460 - Yang , et al. December 2, 2	2008-12-02
Human Glucagon-like-peptide-1 Modulators And Their Use In The Treatment Of Diabetes Related Conditions App 20070238669 - Haque; Tasir Shamsul ; et al.	2007-10-11
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors App 20060287357 - Li; James J. ; et al.	2006-12-21
Inhibitors of 11-beta hydroxysteroid dehydrogenase type I App 20060235028 - Li; James J, ; et al.	2006-10-19
Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators App 20050004151 - Yang, Wu ; et al.	2005-01-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.